MetaCap

Lifevantage (LFVN) vs XBiotech (XBIT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

XBiotech (XBIT) has outperformed Lifevantage (LFVN) over the past year, losing 24.1% versus a loss of 35.5%. Over five years, LFVN leads with a -38.5% price change compared with -86.5% for XBIT. XBiotech is the larger company by market cap ($52.7 million vs $52.6 million), about 1.0 times the size.

On valuation, XBiotech trades at a lower forward P/E (13.3x vs 27.7x for Lifevantage). Lifevantage pays a dividend yielding 4.58%, while XBiotech does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

LFVN-35.46%XBIT-24.12%
+72%+14%-43%
Nov 21, 20251 yearNov 20, 2026
LFVN-43.84%XBIT-86.35%
+259%+78%-103%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

LFVN versus XBIT key metrics
MetricLFVNXBIT
Share price$4.15$1.73
Market cap$52.63M$52.74M
1-day change-15.13%+2.98%
YTD return-32.63%-27.62%
1-year return-35.46%-24.12%
5-year return-38.52%-86.48%
P/E ratio (TTM)19.76—
Forward P/E27.6713.31
EPS (TTM)$0.21$-1.43
Dividend yield4.58%0.00%
Annual dividend$0.19$0.00
Revenue (latest FY)$182.59M—
Revenue growth (YoY)-20.10%—
Net income (latest FY)$5.07M$-45.54M
Gross margin77.56%—
Operating margin3.34%—
Net margin2.78%—
52-week high$11.71$2.73
52-week low$3.90$1.61
Distance from 52-week high-64.56%-36.63%
Analyst consensusnone—
Avg. price target upside+80.72%—
Average volume45.72K64.77K
Shares outstanding12.68M30.49M
Employees20987
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • XBIT has outperformed LFVN by 11.3 percentage points over the past year.
  • Lifevantage offers a meaningfully higher dividend yield (4.58% vs 0.00%).

About Lifevantage

LFVN stock →

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, gut health, and skin and hair care products in the United States and internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; P84 System, a product activator consisting of PhytoPower 1 and PhytoPower 2 that contains probiotics, prebiotics, postbiotics, digestive enzymes, and superfood blends designed to support gut health; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Health Care · Biotechnology: Pharmaceutical Preparations · 209 employees

About XBiotech

XBIT stock →

XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases.

Health Care · Biotechnology: Pharmaceutical Preparations · 87 employees

LFVN vs XBIT FAQ

Which is bigger, Lifevantage or XBiotech?

XBiotech (XBIT) is larger, with a market capitalization of $52.74M compared with $52.63M for Lifevantage (LFVN).

Which stock has performed better over the past year, LFVN or XBIT?

XBIT returned -24.12% over the past 12 months, compared with -35.46% for LFVN (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Lifevantage or XBiotech?

Lifevantage pays a dividend yielding 4.58%, while XBiotech does not currently pay a regular dividend.

Are Lifevantage and XBiotech in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons